What if doctors could diagnose Alzheimer’s and other dementias at earlier stages?
NeuroCog leverages advanced cognitive testing, gaze-tracking technology, and artificial intelligence to enable non-invasive assessments of cognitive resilience.
why we do it
Due to subpar diagnostic methods, doctors miss an irreversible window of opportunity to start treating their patients.
WHAT WE DO
Advanced neurocognitive assessments through gaze-tracking technology.
- Non-invasive
- Early detection
- Comprehensive
HOW WE DO IT
Proprietary gaze-tracking technology based on Artificial Intelligence.
Instant attention measures that double as a remote proctoring tool.
MISSION
NeuroCog aims to contribute to the global goal of reducing the burden of dementia by 50% by 2030. Through continuous detection capabilities and personalized treatment approaches, we strive to improve the management and care of individuals with neurocognitive disorders. By empowering healthcare professionals with advanced tools and insights, we enable timely interventions and enhance the quality of life for patients and their families.
vISION
To create a future where humanity defy the limitations of aging, NeuroCog envisions a world where exceptional cognitive function is sustained beyond 100 years. Through cognitive health monitoring and AI-powered clinical decision support system, we empower people to lead vibrant and fulfilling lives, embracing the boundless possibilities of an ageless mind.